Clinical Trial Update: FTT PET/CT in Pancreatic Neuroendocrine Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating FTT PET/CT imaging in pancreatic neuroendocrine tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Neuroendocrine Carcinoma Metastatic, Pancreatic Tumors | Phase 1 | Status: RECRUITING